Medical dermatology leader eliminates data
silos and gains real-time oversight
PLEASANTON, Calif., Oct. 3, 2023
/PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that LEO
Pharma, a global leader in medical dermatology, is using Veeva
Vault Safety to optimize its safety operations. With this
foundation, the company can seamlessly incorporate affiliates into
safety workflows, boost operational efficiencies, ensure
compliance, and unify its global pharmacovigilance data on one
platform.
"LEO Pharma is deeply committed to the safety of patients using
its products," said Pilar Carrero,
vice president of global safety at LEO Pharma. "With Veeva Vault
Safety, we now have real-time visibility into adverse events and
data transparency for affiliates that helps us work even better
together."
Vault Safety is helping LEO Pharma improve oversight of case
intake, processing, submission, and distribution while simplifying
safety workflows and eliminating data reconciliation with
affiliates and partners. By standardizing drug development on Veeva
Development Cloud, LEO Pharma can better connect safety to other
crucial business areas like clinical, regulatory, and quality.
"Now, all parties have visibility into case data, ownership, and
status, facilitating improved collaboration and sharing of
learnings," said John Lawrie, vice
president of Vault Safety at Veeva. "Veeva is happy to partner with
LEO Pharma to make its safety operations simpler and more
effective."
Vault Safety is a safety case management system that enables
end-to-end adverse event intake, processing, and submission for
clinical and marketed products. It is part of Veeva Development
Cloud, the technology foundation for drug development that brings
together clinical, regulatory, safety, and quality applications to
drive end-to-end business processes.
Additional Information
For more on Veeva Vault Safety, visit: veeva.com/VaultSafety
Connect with Veeva on LinkedIn:
linkedin.com/company/veeva-systems
About Veeva Systems
Veeva is the global leader in
cloud software for the life sciences industry. Committed to
innovation, product excellence, and customer success, Veeva serves
more than 1,000 customers, ranging from the world's largest
biopharmaceutical companies to emerging biotechs. As a Public
Benefit Corporation, Veeva is committed to balancing the interests
of all stakeholders, including customers, employees, shareholders,
and the industries it serves. For more information, visit
veeva.com.
Veeva Forward-looking Statements
This release contains
forward-looking statements regarding Veeva's products and services
and the expected results or benefits from use of our products and
services. These statements are based on our current expectations.
Actual results could differ materially from those provided in this
release and we have no obligation to update such statements. There
are numerous risks that have the potential to negatively impact our
results, including the risks and uncertainties disclosed in our
filing on Form 10-Q for the period ended July 31, 2023, which you can find here (a
summary of risks which may impact our business can be found on
pages 38 and 39), and in our subsequent SEC filings, which you can
access at sec.gov.
Contact:
|
|
Jeremy Whittaker
Veeva Systems
+49-695-095-5486
jeremy.whittaker@veeva.com
|
Deivis Mercado
Veeva Systems
925-226-8821
deivis.mercado@veeva.com
|
View original content to download
multimedia:https://www.prnewswire.com/news-releases/leo-pharma-connects-affiliates-with-veeva-vault-safety-to-transform-safety-operations-301945258.html
SOURCE Veeva Systems